Inappropriate Sinus Tachycardia Registry

NCT ID: NCT05107635

Last Updated: 2025-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-01

Study Completion Date

2027-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inappropriate Sinus Tachycardia Postural Tachycardia Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AtriCure Commercially Available Devices

Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices.
2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements

Exclusion Criteria

1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AtriCure, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University

Palo Alto, California, United States

Site Status RECRUITING

Sequoia Hospital

Redwood City, California, United States

Site Status RECRUITING

University of Florida

Gainesville, Florida, United States

Site Status RECRUITING

Sarasota Memorial Hospital

Sarasota, Florida, United States

Site Status RECRUITING

Kansas City Cardiac Arrhythmia Research

Kansas City, Kansas, United States

Site Status RECRUITING

MedStar Health Research Institute

Hyattsville, Maryland, United States

Site Status RECRUITING

The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital

Cincinnati, Ohio, United States

Site Status RECRUITING

Texas Cardiac Arrhythmia Research Foundation

Austin, Texas, United States

Site Status RECRUITING

Intermountain Medical Center

Murray, Utah, United States

Site Status RECRUITING

Universitair Ziekenhuis Brussels

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Registry Specialist

Role: CONTACT

866-349-2342

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tiffany Koyano

Role: primary

650-724-6921

Juanita Fuji

Role: primary

650-482-6131

Jessica Cobb

Role: primary

352-514-3729

Alexandra Gardner

Role: primary

941-917-8791

Donita Atkins

Role: primary

913-934-4313

Katherine Mahoney

Role: primary

202-877-2806

Anne Voorhorst

Role: primary

513-585-1777

Chantel Scallon

Role: primary

512-807-3150

Lindsey Beven

Role: primary

801-507-4889

Iris Vanzeebroeck

Role: primary

02/476 35 09

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RP-2021-IST

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HEAL-IST IDE Trial
NCT05280093 RECRUITING NA
aVNT in POTS - Pilot
NCT07026643 NOT_YET_RECRUITING NA
Outcome of SVT in Children Admitted to AUCH
NCT07143591 NOT_YET_RECRUITING